Literature DB >> 2578971

Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.

L C Laursen, E Taudorf, Y Gnosspelius, E Gymose, B Weeke.   

Abstract

Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design. The combination of half doses of the 2 drugs produced slightly better bronchodilation than high-dose, single drug regimen and similar bronchodilation as a high-dose combination. Side effects during half dose combination were less than when theophylline alone or high dose combination treatment were administered. High-dose combination treatment produced slightly more ventricular ectopic beats and supra ventricular ectopic beats, and 3 patients developed cardiac arrhythmias. A combination of half the normally used doses of oral slow-release formulations of terbutaline and theophylline seems superior to a high-dose combination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578971

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  5 in total

Review 1.  Oral xanthines as maintenance treatment for asthma in children.

Authors:  P Seddon; A Bara; F M Ducharme; T J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Once-daily theophylline in the treatment of nocturnal asthma.

Authors:  V Vilkka; P Brander; A Hakulinen; J Laitinen; K Sahlström; E Aalto; M Silvasti; P Karttunen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Bambuterol: dose response study of a new terbutaline prodrug in asthma.

Authors:  N H Holstein-Rathlou; L C Laursen; F Madsen; U G Svendsen; Y Gnosspelius; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 4.  Adverse reactions to beta 2-agonist bronchodilators.

Authors:  K M Lulich; R G Goldie; G Ryan; J W Paterson
Journal:  Med Toxicol       Date:  1986 Jul-Aug

5.  Bambuterol: effects of a new anti-asthmatic drug.

Authors:  B K Pedersen; L C Laursen; Y Gnosspelius; P Faurschou; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.